Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
| Website | https://siftbio.com/ |
| Employees | 9 (4 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Mass Spectrometry, Proteomic Analysis, Protein Analysis, Omics Technologies, Biomarker Discovery, Therapeutic Target Identification, High Throughput Screening, Cell Biology, Drug Discovery, Molecular Biology, Biopharmaceutical Research, Systems Biology, Precision Medicine, Life Science Research, Biotechnology, Clinical Diagnostics, Immunology Research, Cancer Research, Next Generation Sequencing |
Looking for a particular Sift Biosciences employee's phone or email?
Yue Lou is the Co-Founder and CEO of Sift Biosciences.
4 people are employed at Sift Biosciences.
Sift Biosciences is based in San Carlos, California.